India to Poland: Vinblastine Export Trade Route

The India to Poland Vinblastine corridor is one of India's established pharmaceutical export routes, with 25 shipments documented worth a combined $59.7K USD. The route is dominated by VAMA LIFECARE PRIVATE LIMITED, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's vinblastine manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $2.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with vinblastine's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 16.9%, placing it at rank #16 among India's top vinblastine export destinations globally.

On the import side, key buyers of Indian vinblastine in Poland include EXP CODE, TO THE, CONCERN PERSON SALUS INTERNATIONAL SP ZO O UL PULASKIEGO and 12 others. EXP CODE is the single largest importer with 3 shipments valued at $28.5K USD.

India's vinblastine exports to Poland are driven primarily by a handful of large-scale manufacturers. VAMA LIFECARE PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VAMA LIFECARE PRIVATE LIMITED, JPC GLOBAL, SARA INTERNATIONAL — together account for 90% of total trade value on this route. The average shipment value of $2.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine for human consumptioninj. vinblastine 10 mg batch no. i23i011b manufacturing date. sep-23 exp date. aug and pharmaceutical product for human use vinblastine sulphate 10mg/10ml inj. each ml contains vinblastine sulphate ip...., suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, EXP CODE is the largest importer with 3 shipments worth $28.5K USD — representing 48% of all vinblastine imports from India on this route. A total of 15 buyers are active on this corridor.